We have received text from H.R. 5256: 340B Affording Care for Communities and Ensuring a Strong Safety-net Act. This bill was received on 2025-09-10, and currently has 1 cosponsor.
Here is a short summary of the bill:
The 340B ACCESS Act is a legislative proposal that focuses on updating and reforming the 340B drug pricing program. The key objectives of the bill are to enhance oversight of the program, clarify eligibility criteria for patients and entities, and regulate contract pharmacies. The aim is to make medications more affordable while ensuring that the operations of the program are transparent and accountable.
Key Provisions
- Pharmacy Requirements: The bill sets forth specific requirements for pharmacies related to licensing and location. These criteria are designed to ensure that pharmacies work appropriately with covered entities under the 340B program.
- Sliding Fee Scale: A sliding fee scale will be implemented to help maintain drug affordability for patients receiving treatment through the 340B program.
- Reporting and Compliance: Covered entities will be required to disclose any noncompliant drug purchases. This includes conducting audits on their operations and being subject to civil penalties for failing to comply with the program's guidelines.
- Charity Care Requirements: To participate in the 340B program, covered entities must also meet annual requirements related to charity care, ensuring that they provide care to low-income patients.
- Enforcement Mechanisms: The bill includes provisions for auditing contracts, penalties for fraudulent claims, and the establishment of a claims data clearinghouse to promote compliance and equity in drug pricing.
Amendments to the Social Security Act
The legislation will amend the Social Security Act to ensure that the same regulations that apply to health plans and issuers also apply to certain contract sponsors and pharmacy benefit managers. This is intended to create a more uniform regulatory approach across the board.
Implementation Timeline
Once the bill is enacted, the provisions outlined will take effect one year later, allowing time for the affected parties to prepare for compliance with the new regulations.
Relevant Companies
- PFE - Pfizer: Likely to be affected as their pricing strategies may need to adjust in response to increased oversight and reporting requirements under the 340B program.
- JNJ - Johnson & Johnson: As a major pharmaceutical company, they may see changes in their partnerships and sales strategies related to 340B covered entities.
- ABBV - AbbVie: Changes to the 340B program could impact how they price and distribute their medications through contract pharmacies.
Representative Earl L. "Buddy" Carter Bill Proposals
Here are some bills which have recently been proposed by Representative Earl L. "Buddy" Carter:
- H.R.5256: To amend the Public Health Service Act to reform the 340B drug pricing program, and for other purposes.
- H.R.5081: Telehealth Modernization Act
- H.R.4975: TOO LATE Act
- H.R.4878: MOSSA Act
- H.R.4838: To establish criminal liability for mayors of sanctuary cities in cases of murder committed by undocumented immigrants within their jurisdiction, and for other purposes.
- H.R.4488: Veterans Health Care Stamp Act
You can track bills proposed by Representative Earl L. "Buddy" Carter on Quiver Quantitative's politician page for Carter.
Representative Earl L. "Buddy" Carter Net Worth
Quiver Quantitative estimates that Representative Earl L. "Buddy" Carter is worth $28.1M, as of September 19th, 2025. This is the 45th highest net worth in Congress, per our live estimates.
Carter has approximately $3.8M invested in publicly traded assets which Quiver is able to track live.
You can track Representative Earl L. "Buddy" Carter's net worth on Quiver Quantitative's politician page for Carter.
Representative Earl L. "Buddy" Carter Stock Trading
We have data on up to $23.1M of trades from Representative Earl L. "Buddy" Carter, which we parsed from STOCK Act filings. Some of the largest trades include:
- A July 18th, 2024 sale of up to $250K of $ABCB. The stock has risen 29.71% since then.
You can track Representative Earl L. "Buddy" Carter's stock trading on Quiver Quantitative's politician page for Carter.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
